Aurinia Receives National Corporate Visionary Award from the Lupus Foundation of America Oct 12, 2017
Aurinia Reports Second Quarter 2017 Financial Results, and Provides Operational Highlights Aug 10, 2017
Aurinia Resolves Temporary Non-Compliance with Nasdaq’s Audit Committee Composition Rule Jul 12, 2017
Aurinia to Host Annual General Meeting of Shareholders and Webcast on June 21 in Vancouver, BC Jun 21, 2017
Aurinia Presents Additional Data from Phase Iib Aura-Lv Study, Demonstrating Stable Renal Function and Blood Pressure without Electrolyte Complications Through 48 Weeks Jun 5, 2017
Aurinia to Participate in Late Breaking Oral Presentations at Two Upcoming Scientific Conferences May 30, 2017
